• The Journal of Korean Physical Therapy
• /
• 제16권2호
• /
• pp.90-98
• /
• 2004

Traumatic brain injury is an insult to the brain caused by an external physical force, that may product a diminished or altered state of consciousness, which results in impairment of cognitive abilities or physical function. The purposes of this study were to overview injury mechanism and neural plasticity of traumatic brain injury. Injury mecanism includes exitotoxicity, production free radical, inflammation and apoptosis. Furthermore traumatic brain injury has protective mechanisms includes production of neural growth factor, heat shock protein, anti-inflammatory cytokines.

• Toxicological Research
• /
• 제17권
• /
• pp.173-183
• /
• 2001

Although there are still many technical difficulties to be overcome, recent advances in the molecular and cellular biology of gene transfer have made it likely that gene therapy will soon start to play an increasing role in clinical practice. However. safety issues are raised from vector system. It is not clear whether it is safe to incorporate genes into nuclear DNA. Little is known about the antigenicity of gene product which the immune system is encountering. In this review, some safety-related topics are introduced and discussed.

• Natural Product Sciences
• /
• 제16권2호
• /
• pp.59-67
• /
• 2010

Flavonoids are well-known anti-inflammatory agents that exert their effects via a variety of mechanisms including antioxidative action, inhibition of eicosanoid metabolizing enzymes and regulation of theexpression of proinflammatory molecules. In this review, synthetic approaches to obtain more useful flavonoid derivatives are summarized. Human clinical trials of flavonoid therapy are discussed. Through continual investigation to identify more potent and comparable flavonoids, new anti-inflammatory flavonoid therapy will be successfully launched, especially for the treatment of chronic inflammatory disorders.

• 한국독성학회:학술대회논문집
• /
• 한국독성학회 2003년도 추계학술대회
• /
• pp.86-86
• /
• 2003

Gene therapy is a medical intervention based on modification of the genetic material of living cells. Gene transfer usually conducted using bacterial plasmid DNA and/or virus vector to express a specific protein. Gene transfer medicinal products classified as naked nucleic acid, complexed nucleic acid or non-viral vectors, viral vector, and genetically modified cells according to biological origin.(omitted)

• 대한안전경영과학회지
• /
• 제12권3호
• /
• pp.341-348
• /
• 2010

The research which sees for a support the government offices will be able to promote a disability firm manufactured product purchase in order with the petal of the disability firm, investigated the public purchase system use and a satisfaction of the disability firm. The plan which is concrete put the goal presents about disability firm manufactured product purchase promotion of the government offices.

• 대한안전경영과학회지
• /
• 제12권3호
• /
• pp.145-151
• /
• 2010

The research which sees the disability firm led and public procurement market penetration the base will be able to grow prepared and with the petal of the disability firm for a support disability firm manufactured product public purchase activation plan of the government offices groped. disability firm manufactured products purchase promotion plan and policy of the government offices presents the fact that with the aim.

• 한국발생생물학회지:발생과생식
• /
• 제21권3호
• /
• pp.343-349
• /
• 2017

tWith the development of the third-generation gene scissors, CRISPR-Cas9, concerns are being raised about ethical and social repercussions of the new gene-editing technology. In this situation, this article explores the legislation and interpretation of the positive laws in South Korea. The BioAct does not specify and regulate 'gene editing' itself. However, assuming that genetic editing is used in the process of research and treatment, we can look to the specific details of the regulations for research on humans as well as gene therapy research in order to see how genetic editing is regulated under the BioAct. BioAct differentiates the regulation between (born) humans and embryos etc. and the regulation differ entirely in the manner and scope. Moreover, due to the fact that gene therapy products are regarded as drugs, they fall under different regulations. The Korean Pharmacopoeia Act put stringent sanctions on clinical trials for gene therapy products and the official Notification "Approval and Examination Regulations for Biological Products, etc." by Food and Drug Safety Administration may be applied to gene editing for gene therapy purposes.

• KSBB Journal
• /
• 제25권2호
• /
• pp.116-122
• /
• 2010

Fermented materials have been used for long time around the world and have been researched according to the excellent effect in the part of medical and food industry. However, when such materials are applied on skin, because of the skin barrier, the most effective ingredients are poorly absorbed. The absorption of the skin is exceedingly limited and the method of increasing skin absorption needs special procedures. The micro-needle therapy is a method used to improve the absorption of drug (solution) in the skin which is called "natural skin rejuvenation therapy". This therapy uses micro-needle which is equipped with very thin, delicate needles smaller than a 0.07 mm thick hair. During this therapy, the micro-needle makes small holes and helps absorb the solution into the skin. This is a very excellent therapy in skin absorption. It can be used in wide regions of the skin without any side effects and no recovery time. In 2007, the micro-needle is permitted to personal care. However, the solutions have not yet been developed professionally, and such skill is needed.

• 대한임상독성학회지
• /
• 제4권2호
• /
• pp.137-142
• /
• 2006

Our records include two cases of DIC in snakebite patients. One patient, who was 48-years old, was bitten in his left ankle 3 days before admission to our hospital. Initial symptoms were painful swelling, extensive ecchymosis, and persistent bleeding at the bite site. He visited and was admitted to a local hospital, but his condition did not improve with supportive care that included a single dose of antivenin. He was transferred to our hospital. His condition was compatible with DIC. We tried multi-dose antivenin therapy and blood product transfusion. At the seventh hospital day, the patient's symptoms were completely resolved. The other patient, who was 75 years old, was bitten in his right thumb. Initial symptoms were painful swelling of the right arm and persistent bleeding at the bite site, and within minutes of hospital admission, the patient experienced massive hematochezia. We peformed laboratory tests, the results of which were compatible with DIC, and the next day a sigmoidscopic examination showed ischemic colitis. We administered multi-dose antivenin therapy and blood product tranfusion. At the third hospital day mild anemia still existed, but the patient's clinical condition was improved. No signs or symptoms of gastrointestinal bleeding were observed. In these two cases, multi-dose antivenin therapy and transfusion effectively resolved symptoms of DIC. Platelet concentrate transfusion was required only for acute thrombocytopenia. After resolution of DIC, platelet counts were returned to normal ranges within a few days. The authors propose that multidose antivenin therapy and coagulation factor transfusion might be useful for improving coagulopathy in snakebite patients.

• 한국환경생태학회지
• /
• 제26권3호
• /
• pp.463-471
• /
• 2012

본 연구는 산림기반형 한방치유 관광상품에 대한 수요자 욕구와 선호를 파악하여 향후 보다 표적화되고 차별화된 산림치유 관련 정책 수립과 한방치유 관련 프로그램의 개발을 위한 기초자료 제공을 목적으로 실시되었다. 서울에 거주하는 30대 이상 성인남녀 400명을 조사대상으로 성과 연령별, 거주지역별로 비례할당 표본추출법을 사용, 인터넷조사(CAWI)를 실시하여 총 317부가 최종 분석에 이용되었다. 산림기반형 한방치유 관광상품에 대한 이미지는 '산림욕, 숲속 걷기, 나무'가 다수(61.5%)를 차지했고, 선호 의견과 이용 의향은 각각 72.9%와 67.5%로 긍정적인 경향이 높았다. 단지 조성에 적합한 지역으로는 수도권이 53.6%, 강원도가 38.8%로 나타났다. 이용목적은 '스트레스 해소와 재충전', '산림휴양활동', '건강 유지 및 체력 증진'의 순이었다. 선호 치유요법은 '트래킹, 산책 등 걷기요법'이 가장 많았으며 '피트니스, 기체조 등 운동요법'이 그 뒤를 이었다. 상품선택 시 주요 고려 요인은 '이용 비용의 적정성', '음식과 이용 식자재의 적절성', '의료진 및 직원들의 친절성' 등으로 나타났으나 이용편의성과 의료서비스의 질, 관광활동 관련 요인 등 전 요인에 걸쳐 높은 점수를 기록하여 상품에 대한 수요자의 높은 기대수준을 보여주고 있다. 또한 인구통계학적 세분시장 별로 이용관련 요인들에 대한 선호에 차이점을 보이고 있어 관련 상품의 기획과 운영 시 차별화 되고 세분화된 수요자 욕구를 반영하는 것이 필요할 것으로 보인다. 그러나 본 연구는 상이한 수요자 선호를 파악함에 있어 인구통계학적 세분 시장만을 규명함으로써 가장 기초적인 단계에 머무른 한계점을 지니고 있어 후속연구에서는 다차원적이고 복합적인 수요자 욕구에 대한 보다 정교화된 규명이 요망된다.